Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect of fenofibrate versus curcumin on glycemic
status, lipids profile, hs-CRP, sirtuin-1 and fetuin-A in type 2 diabetic patients who are
taking glimepiride.